We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial.
- Authors
Weinblatt, Michael E; Bingham, Clifton O, 3rd; Mendelsohn, Alan M; Kim, Lilianne; Mack, Michael; Lu, Jiandong; Baker, Daniel; Westhovens, Rene
- Abstract
Evaluate the efficacy of intravenous golimumab 2 mg/kg+methotrexate (MTX) in patients with active rheumatoid arthritis (RA) receiving MTX.
- Publication
Annals of the rheumatic diseases, 2013, Vol 72, Issue 3, p381
- ISSN
1468-2060
- Publication type
Journal Article
- DOI
10.1136/annrheumdis-2012-201411